Literature DB >> 24096909

Initial combination of injectable and oral anti-tuberculosis agents for the treatment of severe disseminated tuberculosis.

Diego F Boff1, Luciano Z Goldani.   

Abstract

There is a need for intravenous therapy for severe forms of tuberculosis in those who are HIV-positive, diabetic, have cystic fibrosis, extensive gastrointestinal involvement, haemodynamic instability with difficulty to take and absorb oral medications, which results in a lack of appropriate therapeutic effect during treatment, such as not creating the optimal blood concentration of the substance. We report an HIV-infected patient presenting with severe disseminated tuberculosis with extensive intestinal involvement which was successfully treated with an initial combination regimen of injectable and oral anti-tuberculosis agents. We discuss and emphasize the importance of an initial regimen with injectable and oral agents for treating severe forms of tuberculosis.

Entities:  

Keywords:  Injectable anti-TB agents; intestinal involvement; tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 24096909     DOI: 10.1177/0049475513502961

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  4 in total

1.  Abdominal tuberculosis: an old disease surprising young doctors.

Authors:  Marta David Sousa; Joana Batista; Patricia Pacheco; Vitor Nunes
Journal:  BMJ Case Rep       Date:  2016-11-02

2.  Management of Severe Gastrointestinal Tuberculosis with Injectable Antituberculous Drugs.

Authors:  Luciano Z Goldani; Camila O Spessatto; Daltro L Nunes; Juliana G Oliveira; Eliziane Takamatu; Carlos T Cerski; Helena A S Goldani
Journal:  Trop Med Health       Date:  2015-06-24

3.  The initial intravenous treatment of a human immunodeficiency virus-infected child with complicated abdominal tuberculosis.

Authors:  Anthony K Enimil; Brian Eley; James Nuttall
Journal:  South Afr J HIV Med       Date:  2020-08-24       Impact factor: 2.744

4.  Severe gastrintestinal bleeding as an unusual presentation of pediatric tuberculosis: a situation for injectable antituberculous drugs use?

Authors:  Ana Carolina Etrusco Zaroni Santos; Jaques Sztajnbok; Amaro Nunes Duarte-Neto; Amanda Freire Tamburini Sousa; Alessandra Geisler Daud Lopes; Anna Carlota Mott Barrientos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-10-30       Impact factor: 1.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.